Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proton MR spectroscopy in multiple sclerosis.

D L Arnold1, N De Stefano, S Narayanan

  • 1Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada H3A 2B4.

Neuroimaging Clinics of North America
|May 22, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic liver preservation: current evidence and future challenges.

Acta gastro-enterologica Belgica·2025
Same author

Neurological research in Italy from 2020 to 2023.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2023
Same author

Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a.

Journal of neurology·2023
Same author

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

Peak width of skeletonized mean diffusivity (PSMD) and cognitive functions in relapsing-remitting multiple sclerosis.

Brain imaging and behavior·2020
Same author

Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.

AJNR. American journal of neuroradiology·2020
Same journal

State-of-the-Art Epilepsy Imaging: Improving Tools for Epileptogenic Lesion Detection and Treatment.

Neuroimaging clinics of North America·2026
Same journal

Imaging of Epilepsy.

Neuroimaging clinics of North America·2026
Same journal

Implanted Devices for Management of Drug-Resistant Epilepsy: Background and MR Imaging Considerations.

Neuroimaging clinics of North America·2026
Same journal

Imaging of Epilepsy Surgery, Minimally Invasive Techniques, and Neuromodulation.

Neuroimaging clinics of North America·2026
Same journal

Neuroimaging and the Epilepsy Journey.

Neuroimaging clinics of North America·2026
Same journal

Clinical Functional Magnetic Resonance Imaging in Epilepsy.

Neuroimaging clinics of North America·2026
See all related articles

Multiple sclerosis (MS) causes irreversible disability through axonal injury. Early inflammation control is crucial to prevent permanent damage and disability progression in MS patients.

Area of Science:

  • Neuroscience
  • Immunology
  • Neurology

Background:

  • Axonal injury is a key factor in multiple sclerosis (MS) pathogenesis.
  • Injury can be focal or diffuse, leading to irreversible neurological deficits.
  • Acute inflammatory events in MS may involve reversible axonal injury, explaining early remissions.

Purpose of the Study:

  • To highlight the direct link between axonal injury and irreversible disability in MS.
  • To underscore the importance of early inflammation management in mitigating MS progression.
  • To provide a rationale for therapeutic interventions targeting inflammation early in the disease course.

Main Methods:

  • This study is a review and synthesis of existing research on MS pathology.
  • Analysis of the relationship between inflammatory processes and axonal damage in MS.

Related Experiment Videos

  • Correlation of clinical disability with the extent of axonal injury.

    • Main Results:

    • Axonal injury in MS is a primary driver of permanent disability.
    • Early inflammatory attacks can cause reversible axonal injury, contributing to temporary recovery.
    • Significant axonal injury is present by the time clinical disability becomes apparent.

    Conclusions:

    • Early and effective limitation of inflammation is essential in managing MS.
    • Interventions aimed at reducing inflammation early can prevent irreversible axonal damage.
    • Controlling inflammation is critical for preserving neurological function and reducing long-term disability in MS.